97 results about "Tenosynovitis" patented technology

Provided are methods for enhancing exercise (e.g., intense, eccentric, elevated temperature, repetitive, aerobic, and high altitude) performance, comprising administering electrokinetically-altered aqueous fluids comprising an ionic aqueous solution of stably configured charge-stabilized oxygen-containing nanostructures predominantly having an average diameter of less than 100 nanometers. In certain aspects, enhancing exercise performance comprises at least one of: reducing plasma inflammatory cytokines (e.g., IFN-alpha, ENA-78 and BDNF); ameliorating muscle / tendon damage or enhancing muscle / tendon recovery; reducing biomarkers of exercise-induced muscle injury (e.g., CK, plasma myoglobin); ameliorating exercise induced tendinosis, tendonitis, tenosynovitis, avulsion, and tendon strain associated with chronic repetitive movement or enhancing recovering therefrom; increasing VO2 max; decreasing RPE; reducing blood lactate; preserving muscle contractile function (e.g., maximal force, joint ROM); reducing muscle soreness; ameliorating onset of fatigue in an excercising subject. Improved methods for producing electrokinetically altered aqueous fluids (including sports beverages) are also provided.

The invention provides a flurbiprofen hydrogel plaster and a composition thereof. In the composition, the content of flurbiprofen is 0.1-3wt%, and a hydrogel substrate accounts for the rest. Based on the total weight of the hydrogel substrate, the hydrogel substrate comprises the following components: 0.1-40wt% of a hydrophilic base material, 0.01-2wt% of a crosslinking agent, 0.01-4wt% of a crosslinking regulator, 10-60wt% of a humectant, 0.05-45wt% of a penetration enhancer and 10-85wt% of a solvent. According to the flurbiprofen hydrogel plaster provided by the invention, a small number of medicines are used, and the permeability and stability are good; and the flurbiprofen hydrogel plaster can be applied to various arthralgia diseases such as rheumatic arthritis, gouty arthritis, ankylosing spondylitis, tenosynovitis, muscle pain and lumbago.

The invention relates to a health care product, in particular to a pain relieving patch for hyperosteogeny. According to the prescriptive proportion, the invention is made from effective ingredients and auxiliary materials, wherein the effective ingredients of the invention are raw radix aconiti, raw radix aconiti feri, clematis root, garden balsam stem, rhizoma arisaematis, raw pinellia ternate,raw olibanum, raw myrrh, nux vomica and the auxiliary materials are borneol, camphor, methylsalicylate, star anise oil, glycerol and azone. The invention is suitable for relieving the pain of patients suffering from rheumatism and rheumatoid arthritis, hyperosteogeny, scapulohumeral periarthritis, cervical spondylosis, lumbar intervertebral disc proptosis, lumbar muscle strain, stiff neck, tenosynovitis, costal chondritis. The invention has the advantages of simple medicine compound, low cost, convenient usage and significant effect, no poison, no irritation and relieving pains according to the results of test.

The invention relates to a drug for treating arthrophlogosis. The drug is prepared from the following traditional Chinese medicine materials: radix angelicae pubescentis, incised notopterygium, root of red-rooted salvia, root bark of the peony tree, dried rhizome of rehmannia, flowers carthami, scutellaria baicalensis, golden cypress, honeysuckle and scorpio. In addition, the materials of cassia twig and asarum, or coix seed, radices sileris and radix clematidis, or angelica sinensis, radix achyranthis bidentatae, lycopodium clavatum, eucommia ulmoides, parasitic loranthus, fruit of Chinese wolfberry, radix ophiopogonis and ginseng, or liquorice, drynaria rhizome and ligusticum wallichii are respectively added aiming at different symptoms of arthrophlogosis. The drug can be used for treating rheumatic arthritis and rheumatoid arthritis, scapulohumeral periarthritis, tenosynovitis, arthromeningitis, joint tissue injury and traumatic injury, and is high in recovery rate and free of adverse side effect.

The invention discloses a celecoxib pellet preparation, which is used for treating rheumatic arthritis, osteoarthritis and ankylosing spondylitis, and also can be used for treating acute pain, dysmenorrheal, colorectal polyps, post-operation analgesia, low back pain, periarthritis of shoulder and tenosynovitis. According to the celecoxib new formulation and the preparation method thereof, the pellet preparation technology and the controlled-release pellet upper covering technology are adopted and microcrystalline cellulose pills are selected for dissolving the celecoxib material medicines in adhesive povidone solution, the medicine materials are uniformly sprayed on the surface of the pills and covered with isolating layers, so that the pellet is pressed and capsule. When the disintegration time limit of the celecoxib pellet preparation is remarkably shortened and the bioavailability is remarkably improved.

The external medicine for treating traumatic injury with fast effect is prepared with eight kinds of Chinese medicinal materials including angelica, frankincense, myrrh, safflower, ledebouriella root, etc. as well as rosin and sesame oil. It has the functions of stopping pain, stopping itching, promoting blood circulation, elimianting blood clots, etc. It has high curative effect on tendon injury, sprain, fracture and other closed traumatic injury and has also certain curative effect on frostbite, scapulohumeral periarthritism tenosynovitis and hyperplasia of mammry glands.

The invention relates to a compound electret membrane, a preparation method thereof and the use thereof and belongs to the field of medical appliances. The compound electret membrane is produced from a porous membrane PTFE, FEP, PP and a blood-activating clot-dispersing Chinese medicament which is an ethanolic extract of notoginseng root, or dragon's blood or a pharmaceutical composition of the ethanolic extract of notoginseng root and the dragon's blood. The method adopts a melting process to prepare a PTFE / FEP electret membrane, adopts a corona induced plasma chemical process to make an electret and compounds a PP membrane and the PTFE / FEP electret membrane which carry the blood-activating clot-dispersing Chinese medicament to produce a novel compound electret membrane. The obtained compound electret membrane has the effects of quickly reliving pain, activating blood and dispersing clot, resisting inflammatory, promoting fracture healing and microcirculation, improving Joint movement and functions and suppressing arthrosis. The compound electret membrane is applicable to the symptoms of primary or secondary arthropathy, osteoarthropathy, sports injury, lumbago, tenosynovitis, osteoporosis, hyperosteogeny, rheumatoid arthritis, and the like.

The invention discloses a blood-activating, pain-relieving and bone-strengthening ointment, which is an external ointment. The blood-activating, pain-relieving and bone-strengthening ointment is prepared from saffron, dragon's blood, long-noded pit viper, gastrodia elata, musk tibetene, menthol, borneol, and has the effects of relaxing muscles and stimulating blood circulation, relieving swelling and pains, removing stasis and mass, reunioning fractured tendons and bones, dispelling wind and eliminating dampness, warming and activating meridian, removing necrotic tissue and promoting granulation and the like. The ointment can be widely applied to the surgical department, the pediatrics department, the gynecology department and other clinical departments, can be used for treating sore pain, burning pain, sciatica, arthralgia caused by hyperosteogeny, lumbar muscle strain, oil injury of bone fracture, bone spur, arthritis, aged rheumatism, rheumatoid arthritis, lumbar disc herniation, periostitis, bone tuberculosis, osteomyelitis, tenosynovitis, ankylosing spondylitis, scapulohumeral periarthritis, spinal stenosis, mid-early femoral head necrosis, soft tissue injury or cartilage wear, or clinical common pain symptoms caused by deformed joints, muscle weakness, numb, stiffness, muscle paralysis, atrophy and other reasons.

Belonging to the technical field of medicine, the invention discloses a pharmaceutical composition for treatment of soft tissue injuries. The pharmaceutical composition comprises the following components by weight: 16-20 parts of Chinese angelica, 16-20 parts of Ligusticum wallichii, 7-11 parts of panax notoginseng, 7-11 parts of safflower, 7-11 parts of peach kernel, 7-11 parts of eucommia, 7-11 parts of dried tangerine peel, 7-10 parts of radix aconiti preparata, and 7-10 parts of processed radix aconiti kusnezoffii. The pharmaceutical composition provided by the invention can reach quick swelling diminishing and pain relieving on various closed soft tissue injuries, and promote soft tissue's quick restoration of normal functions, has an effective rate up to 100% on acute sprain and contusion, muscle strain, and articular ligament strain, the cure rate is up to 100%, the course of treatment is short, usually swelling can be eliminated within 24 hours, and full-recovery can be achieved within one week. For chronic tenosynovitis and periarthritis of shoulder, the effective rate is up to 100%, and the cure rate is up 95% or more. With the characteristics of exact curative effect, small toxic and side effect and low cost, the pharmaceutical composition can greatly mitigate patients' financial burden and mental burden.

The invention discloses a traditional Chinese medicine composition for treating tenosynovitis. The traditional Chinese medicine composition comprises 20-30g of monkshood, 10-20g of radix aconiti agrestis, 10-20g of folium artemisiae argyi, 10-20g of angelica sinensis, 10-20g of ligusticum wallichii, 10-20g of dipsacus asperoides, 10-20g of lycopodium clavatum, 8-15g of radix clematidis, 8-12g of caulis sinomenii, 8-12g of cassia twig, 8-12g of garden balsam stem, 8-12g of radix cyathulae, 8-12g of safflower carthamus, 8-12g of ramulus mori, 8-12g of polygala tenuifolia and 8-12g of akebiaquinata, wherein the medicines are excellent in compatibility and reasonable in formula, and co-exert the effects of tonifying qi and strengthening exterior, activating blood circulation and stimulating meridians, relaxing tendons and activating collaterals, and dispelling wind and eliminating dampness; the traditional Chinese medicine composition has the advantages of being simple and practicable, convenient to operate, fast to become effective, free from side effects and the like in case of being used for treating tenosynovitis, avoids invasive operations, reduces the pain of patients, as well as is capable of effectively and thoroughly curing tenosynovitis, reducing recurrence, improving the living quality of the patients, and worthy of clinic popularization and application.

The invention discloses an external tincture for treating bone poliomyelitis and a preparation method of the external tincture. The external tincture comprises the following ingredients in parts by weight: 18-24 parts of radix aconiti, 18-24 parts of peach kernel, 18-24 parts of radix aconiti carmichaeli, 15-22 parts of dried tangerine or orange peel, 10-18 parts of folium artemisiae argyi, 18-25 parts of radix clematidis, 25-30 parts of semen brassicae, 10-15 parts of tuberculate speranskia herb, 10-20 parts of safflower carthamus, and 0.5-1.5 parts of musk. The external tincture in reasonable in compatibility of medicines, can treat various bone poliomyelitis effectively, such as cervical spondylopathy, scapulohumeral periarthritis, pain in waist and lower extremities, traumatic injury, sciatica, rheumatic arthritis, rheumatoid arthritis, hyperostosis, spinal stenosis, tenosynovitis, synovitis, gout, years of old injury, lumbar disc herniation, osteonecrosis of the femeral head, swelling, limp and numb, pain and the like caused by qi-stagnancy and blood stasis and blockage of meridians, is simple in formula, is good in osmotic effect, and is remarkable in treatment effect.

The invention discloses an analgesic ointment with the function of relaxing tendons and activating collaterals, which is composed of the following ingredients: lovage, angelica, notopterygium, angelica, shenjincao, eucommia, clematis, achyranthes bidentata, rhizome rhizome, and bone supplement Fat, Aconitum, Speranthum, Nuxychia, Chuanduan, Safflower, Fangfeng, Wholeworm, Centipede, Frankincense, Myrrh, Dried Blood, Borneol, Camphor. The ointment of the present invention has strong penetrating power, quick drug effect, strong muscles and bones, expelling cold and dehumidification, promoting blood circulation, reducing swelling, relieving pain, dredging meridians, and can treat frozen shoulder, headache, swelling and numbness, lumbar disc disease caused by neck thrust disease. Sciatica caused by protrusion, numbness and pain in the waist and legs, lumbar muscle strain, ankylosing spondylitis, soft tissue contusion, unknown mass, mammary gland mass, tenosynovitis, rheumatic pain and other pain diseases have obvious curative effects.

The present invention relates to novel strains of avian reovirus that were isolated from clinical cases of viral arthritis / tenosynovitis in chickens in the southeast United States. The invention is directed to these novel group 1 and group 2 avian reoviruses, diagnostic assays using antibodies and / or nucleotide- or amino acid-specific components of such viruses, such as the S1 gene encoding the sigma C protein, and to vaccines that protect chickens from disease caused by such viruses.

The invention provides an indomethacin cataplasm, which is composed of a backing, a paste body, and an anti-sticking film, wherein the paste body is composed of indomethacin, crotamiton, N-methyl pyrrolidone, and hydrogel matrix; the content of the indomethacin in the paste body is 0.1 to 3 wt%, the weight of crotamiton is 0.1 to 6 times as heavy as that of indomethacin, the weight of N-methyl pyrrolidone is 1 to 15 times as heavy as that of indomethacin, and the balance being hydrogel matrix. The mixed solvent of crotamiton and N-methyl pyrrolidone can increase the solubility of indomethacin so as to completely dissolve indomethacin, the indomethacin is evenly dispersed in hydrogel matrix and will not crystallize for a long time, moreover the skin penetrating performance of indomethacin is improved, and indomethacin can be more easily absorbed by the skin. Furthermore, a skin penetration promoter and a wetting agent are added to ensure that the cataplasm has a high water content and remains wet for a long time, and the skin penetration and absorption of the drugs are also promoted. The provided indomethacin cataplasm can be used to treat arthralgia diseases such as rheumatic arthritis, gouty arthritis, rigidity myelitis, tenosynovitis, and the like.

The invention relates to a Chinese medicinal paste for treating tenosynovitis, which comprises the following medicaments in part by weight: 8 to 15 parts of rhubarb, 8 to 15 parts of raw gardenia, 8 to 15 parts of safflower, 8 to 15 parts of peach seed, 8 to 15 parts of frankincense, 8 to 15 parts of myrrh, 20 to 40 parts of common clubmoss herb, 20 to 40 parts of garden balsam stem, 8 to 15 parts of dried ginger, 8 to 15 parts of mulberry twig, 8 to 15 parts of menispermaceae, 8 to 15 parts of fortune's drynaria rhizome and 10 to 20 parts of ground beetle. The invention also provides a preparation method for the Chinese medicinal paste for treating tenosynovitis, which comprises the following steps of: weighing the medicaments according to a weight part ratio, and grinding to 200 to 400-mesh fine powder; soaking the medicaments in more than 60 percent alcohol; adding 50 to 100 weight parts of castor oil, and blending to form paste; and applying to white yarn uniformly to form the Chinese medicinal paste.

The invention relates to a black plaster for treating intervertebral disc herniation. The black plaster comprises the following components in parts by weight: 10 parts of carthamus tinctorius, 20 parts of Ligusticum wallichii, 50 parts of semen strychni, 30 parts of raw frankincense, 30 parts of myrrh, 30 parts of unprocessed rhizoma arisaematis roots, 30 parts of unprocessed radix aconiti, 25 parts of radix angelicae pubescentis, 20 parts of garden balsam stems, 50 parts of wine-treated rhubarb, 30 parts of drynaria rhizome, 20 parts of dried bodies of scorpion, 20 parts of ground beetles, 50 parts of zaocys dhumnades, 20 parts of draconis sanguis, 25 parts of borneol, 200 parts of rosin, 1000 parts of plumbum rubrum and 2500 parts of plant oil. The black plaster has good treatment effects on intervertebral disc herniation, cervical spondylosis, scapulohumeral periarthritis, traumatic injury, arthritis, hyperostosis, rheumatism, rheumatoid and tenosynovitis, and is long in pharmacological effect.

The invention discloses a medicine for treating tenosynovitis. The medicine consists of the following medicinal raw materials in parts by weight: 12-18 parts of morinda officinalis, 12-18 parts of rhizoma cibotii, 8-12 parts of folium artemisiae argyi, 8-12 parts of ligusticum wallichii, 8-12 parts of carthamus tinctorius, 8-12 parts of radix curcumae longae, 8-12 parts of pepper, 8-12 parts of dried ginger, 8-12 parts of herba lycopi, 8-12 parts of verbena officinalis, 8-12 parts of caulis spatholobi and 8-12 parts of cortex moutan. The medicine is decocted by the following steps: boiling the morinda officinalis, the rhizoma cibotii, the folium artemisiae argyi, the ligusticum wallichii, the carthamus tinctorius, the radix curcumae longae, the pepper, the dried ginger, the herba lycopi, the verbena officinalis, the caulis spatholobi and the cortex moutan in the medicinal raw materials in water with the weight being 3 times the total weight of the boiled materials for 10-15min, soaking the materials for 5-8min, filtering so as to obtain a medicine liquid, reserving dregs for secondary decoction and combining medicine liquids, so that the medicine is obtained. By combining the various medicinal materials in use, the medicine disclosed by the invention, on treating the tenosynovitis, is significant in effect and obvious in curative effect.

The invention relates to a traditional Chinese medicine nursing composition for treating tenosynovitis. The traditional Chinese medicine nursing composition is prepared from, by weight, 5-8 parts of sculellaria barbata, 3-7 parts of sinomenium acutum, 2-4 parts of zanthoxylum nitidum roots or leaves, 5-10 parts of salvia miltiorrhiza, 3-5 parts of parthenocissus tricuspidata, 2-7 parts of lamium amplexicaule, 1-3 parts of euonymus yunnanensis rhizomes, 1-4 parts of nepeta angustifolia, 2-4 parts of elsholtzia fruticosa, 3-5 parts of hedychium coronarium, 3-5 parts of mysore thorn roots, 5-8 parts of caesalpinia sappan, 1-3 parts of iris confusa and 1-2 parts of gynura segetum. The traditional Chinese medicine nursing composition has the effects of promoting blood circulation to remove blood stasis, relieving swelling and pain, warming channels to stop spasm, and dredging the channels, is safe, free of toxic and side effects and high in cure rate and has the remarkable effect of treating tenosynovitis.

Provided is a wrist joint bandage having a taping function capable of preventing tenosynovitis of the hand by reducing a burden on the wrist joint. A wrist joint bandage 100 comprises: a band-shaped main body part 10 which is woven in a fabric having a loop face 13 of a touch fastener and is composed of a winding part 11 which is wound around the wrist of a wearer, and a supporting part 12 which is disposed from the back of the hand or the palm to the wrist of the wearer; an anchor part 20 which is joined to one end 10a of the main body part 10 and into which a finger of the wearer is inserted; and an engaging part 30 which is joined to the other end 10b of the main body part 10 and has a hook face 33 of a touch fastener, which is detachably stuck to the loop face 13 of the main body part 10.

The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and chondroitin sulfate to be used in the treatment of osteoarthritis, of subchondral damage, osteoporosis, synovitis, tenosynovitis, tendinitis, tendinosis, as an intra-articular washing liquid and as a viscous substitute of synovial fluid following osteochondral surgery. These formulations are also suitable for the treatment of interstitial cystitis.

The invention discloses a plaster for promoting wind dampness arthralgia syndrome muscle and bone ache rehabilitation. The plaster comprises a fried material A and a fine material B. The plaster has the advantages of realization of medicine effects going through skins and mucous membranes and directly reaching the disease focus due to external use of medicines, short treatment course, reduction of toxic and side effects brought by oral administration, low production cost, good curative effect and good rehabilitation promotion effects. The plaster has the efficacy of warming meridians and dispelling cold, tonifying qi and nourishing blood, activating blood circulation and dissipating blood stasis, strengthening tendons and bones, relaxing muscles and tendons and activating collaterals, eliminating inflammations and discharging toxins, dispelling wind and dampness, softening spurs, and tonifyign kidney and nourishing bones, promotes rehabilitation of aches caused by dampness arthralgia syndrome muscles and bones, has a substantial treatment effect on aches caused by rheumatoid arthritis, rheumatoid arthritis, ankylosing spondylitis, gouts, cervical spondylopathy, scapulobumeral periarthritis, lumbar disc protrusion, sciatica, hyperosteogeny, calcaneal spur, meniscus injury, synovitis, tennis elbow, tenosynovitis, free bones, soft tissue injury, bone joint degeneration, traumatic injury and fracture sequelae in western medicinal science, and has an effective rate reaching 98%.

The invention discloses celecoxib effervescent tablets which are used for treating rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. The tablets can also be used for treating acute pain, dysmenorrhea, colorectal polyps and post-operative analgesia, lower back pain, shoulder periarthritis and tenosynovitis. According to the invention, celecoxib is adopted as a raw material, and auxiliary materials are added, such that the celecoxib effervescent tablets are prepared. The celecoxib effervescent tablets have the advantages of fast disintegration, fast absorption high bioavailability, convenient application, low intestinal residue, low side effect, and sweet taste and good fragrance. With the tablets and the method, patient medication compliance can easily be improved.

The invention relates to edible mushroom inoculating, in particular to an edible mushroom injection inoculating device which comprises a workbench, an edible mushroom culture bag, a stepping motor, agantry hanging bracket, a control display, a puncture inoculating mechanism, a self-cleaning punching mechanism, a double-track bag-binding material-stirring mechanism and a toolkit. The edible mushroom culture bag is arranged in the middle of the top end of the workbench, the inner left middle of the workbench is in bolt connection with the stepping motor, the top end left portion and the top endright portion of the workbench are welded with the gantry hanging bracket, and the puncture inoculating mechanism is arranged on the top end left portion of the workbench. The device has the advantages that a good closed state before and after inoculation is realized, infectious microbe contamination is prevented, contact of people with fungi is reduced, and frequent attack of tenosynovitis caused by manual bag binding can be prevented.

The invention discloses a wrist band for preventing tenosynovitis, which comprises a wrist band sleeve, wherein a medicine bag ring is arranged in the wrist band sleeve; the medicine bag ring is parallel to the wrist band sleeve; and the medicine bag ring contains the following medicines in part by weight: 8 to 15 parts of safflower, 8 to 15 parts of peach kernels, 5 to 12 parts of herba ephedrae, 10 to 20 parts of red paeony root, 8 to 15 parts of frankincense, 8 to 15 parts of myrrh, 20 to 40 parts of lycopodium clavatum, 10 to 30 parts of caulis sinomenii, 8 to 15 parts of heracleum, 8 to 15 parts of himalayan teasel root, 5 to 15 parts of as arum, 8 to 15 parts of bark of eucommia, 8 to 15 parts of drynaria rhizome, 10 to 30 parts of Chinese polyphaga and 10 to 30 parts of twotooth achyranthes. The medicine bag ring also contains a neodymium-iron-boron permanent magnet. When used, the wrist band can be worn on wrist by a user at anytime for promoting qi and blood circulation, improving local circulation, repairing injured tissues and preventing repeated outbreak of diseases.

The invention discloses a Chinese medicinal composition for treating tenosynovitis, which is characterized in that raw materials comprise the following components according to the weight proportion: 10 portions of nuxvomica, 10 portions of gardenia, 10 portions of frankincense, 10 portions of myrrh, 10 portions of Chinese ephedra, 12 portions of liquorice, and a proper amount of honey. A method for preparing the Chinese medicinal composition for treating the tenosynovitis is characterized by taking various component medicaments according to the weight proportion, grinding the mixture into powder, passing through a 100-mesh sieve, adding a proper amount of honey after the mixture is mixed and stirred evenly, and stirring into paste for use. The medicament has the efficacies of dredging channels and resolving hard mass, activating blood and promoting qi, clearing heat and releasing toxin, dispelling stasis, reducing swelling, and relieving pain after the compatibility, and aims to achieve the aim of healing the tenosynovitis. The Chinese medicinal composition has the characteristics of novel combination of Chinese medicinal raw materials, low cost, convenient preparation, no toxic side effect, and remarkable effect.

The invention belongs to the field of traditional Chinese medicine technologies, and particularly relates to a traditional Chinese medicine composition for the treatment of tenosynovitis. The traditional Chinese medicine composition for the treatment of tenosynovitis is composed of the following herbal materials in parts by weight: 18-25 parts of radix dipsaci, 15-22 parts of herba asari, 16-25 parts of lotus plumule, 9-17 parts of herba androsacis, 20-30 parts of radix clematidis, 10-22 parts of rhizoma zedoariae, 12-22 parts of rhizoma corydalis, 15-25 parts of raw rhubarb, 25-40 parts of lycopodium clavatum, 10-15 parts of musk, 12-19 parts of semen raphani, 15-20 parts of eupolyphoge sinensis, 25-38 parts of olibanum, 15-30 parts of fructus psoraleae, 16-22 parts of chorion ovi, 9-16 parts of manyleaf paris rhizome, 30 parts of Vaseline and 30 parts of lanolin. The traditional Chinese medicine composition disclosed by the invention is prepared from Chinese herbal medicines which are matched scientifically to take the synergistic effect; the traditional Chinese medicine composition has the effects of promoting blood circulation to remove blood stasis, relaxing tendon and activation collaterals; and the traditional Chinese medicine composition is short in course of treatment, high in rate of treatment, and worth popularizing, and takes effect quickly.

The invention discloses a traditional Chinese medicine preparation used for treating extensor carpi tenosynovitis. The traditional Chinese medicine preparation comprises a medicine for oral administration and a medicine for external application; the medicine for oral administration comprises herba dendrobii, folium perillae, herba ephedrae, herba lycopodii, lumbricus, angelica sinensis, flos carthami, pericarpium zanthoxyli, radix cyathulae, prepared carapax et plastrum testudinis, medicated leaven, polygala tenuifolia, and honey-fried licorice root; and the medicine for external application comprises folium artemisiae argyi, herba aristolochiae mollissimae, fresh ramulus mori, cassia twig, caulis sinomenii, rhizoma zingiberis, mint, caulis trachelospermi, borneol, herb of tuberculate speranskia, and flos lonicerae. The ratio of the Chinese herbal medicines is reasonable; and the traditional Chinese medicine preparation is mild, is capable of treating based on pathogenesis effectively, easing joint movement, and relieving swelling and pain. The traditional Chinese medicine preparation is capable of improving human immunity via adjusting human endocrine systems; and blood circulation and immune systems of nidus can be adjusted directly by the medicine for external application, so that treatment of extensor carpi tenosynovitis can be realized.

The invention discloses a drug used for diminishing inflammation, invigorating blood circulation, and dredging collaterals, and belongs to the field of traditional Chinese medicine preparation. The drug comprises semen strychni, raw radix aconiti, raw radix aconiti kusnezoffii, raw rhizoma pinelliae, raw arisaema heterophyllum blume, radix clematidis, peach kernel, resina ferulae, realgar, herba lycopodii, drosera peltata, phryma leptostachya, rhizoma corydalis decumbentis, rhizoma paridis, herba ephedra, cortex eucommiae, cassia twig, herba asari, cortex cinnamomi, calamus tetradactylus, rhizoma corydalis, and pseudo-ginseng. The drug is capable of softening hardness to dissipate stagnation, removing wind and dampness, and promoting blood circulation to remove meridian obstruction; applying the ingredients above to infected parts possesses obvious curative effects on traumatic injuries, joint pain, cervical spondylosis, lumbar disc herniation, tenosynovitis, ganglion, radiohumeral bursitis, myofascitis, ankylosing spondylitis, achilles tendinitis, muscle strain, rheumatism, and rheumatoid arthritis.